These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 31978433

  • 1. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC, Lopriore E, Zwiers C, Böhringer S, Janssen MWM, Oepkes D, De Haas M.
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S, Nupponen I, Kuosmanen M, Aitokallio-Tallberg A, Ekholm E, Halmesmäki E, Orden MR, Palo P, Raudaskoski T, Tekay A, Tuimala J, Uotila J, Stefanovic V.
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [Abstract] [Full Text] [Related]

  • 3. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM, Lindenburg IT, Koelewijn JM, Van Kamp IL, Oepkes D, De Haas M.
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP, Widness JA.
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [Abstract] [Full Text] [Related]

  • 6. Fetal and Neonatal Reticulocyte Count Response to Intrauterine Transfusion for the Treatment of Red Blood Cell Alloimmunization.
    Lee AJ, Leonard A, Markham KB.
    J Pediatr Hematol Oncol; 2022 Nov 01; 44(8):e1046-e1049. PubMed ID: 35380549
    [Abstract] [Full Text] [Related]

  • 7. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.
    Thorp JA, O'Connor T, Callenbach J, Cohen GR, Yeast JD, Albin J, Plapp F.
    Am J Obstet Gynecol; 1991 Jul 01; 165(1):79-81. PubMed ID: 1853921
    [Abstract] [Full Text] [Related]

  • 8. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.
    Scaradavou A, Inglis S, Peterson P, Dunne J, Chervenak F, Bussel J.
    J Pediatr; 1993 Aug 01; 123(2):279-84. PubMed ID: 8345428
    [Abstract] [Full Text] [Related]

  • 9. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
    Moise KJ, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB, UNITY Study Group.
    N Engl J Med; 2024 Aug 08; 391(6):526-537. PubMed ID: 39115062
    [Abstract] [Full Text] [Related]

  • 10. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.
    Am J Obstet Gynecol; 2018 Sep 08; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [Abstract] [Full Text] [Related]

  • 11. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S, al Omran A.
    J Perinat Med; 1999 Sep 08; 27(2):112-5. PubMed ID: 10379500
    [Abstract] [Full Text] [Related]

  • 12. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, Estle L.
    Am J Obstet Gynecol; 1991 Nov 08; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [Abstract] [Full Text] [Related]

  • 13. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
    Lakhwani S, Machado P, Pecos P, Coloma M, Rebollo S, Raya JM.
    Transfus Apher Sci; 2011 Aug 08; 45(1):9-11. PubMed ID: 21723196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U, Larsson M, Baird A, Waring G, Athiraman N.
    J Matern Fetal Neonatal Med; 2022 Dec 08; 35(25):10220-10225. PubMed ID: 36121063
    [Abstract] [Full Text] [Related]

  • 16. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
    Manoura A, Korakaki E, Hatzidaki E, Saitakis E, Maraka S, Papamastoraki I, Matalliotakis E, Foundouli K, Giannakopoulou C.
    Pediatr Hematol Oncol; 2007 Dec 08; 24(1):69-73. PubMed ID: 17130116
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I, Schlenke P, Härtel C.
    Transfusion; 2010 May 08; 50(5):1064-70. PubMed ID: 20003047
    [Abstract] [Full Text] [Related]

  • 19. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C, Rakza T, Thomas D, Wibaut B, Vaast P, Subtil D, Houfflin-Debarge V.
    Eur J Pediatr; 2015 Nov 08; 174(11):1535-9. PubMed ID: 26032762
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.